13 results
10-K
2020 FY
INZY
Inozyme Pharma Inc
25 Mar 21
Annual report
6:21am
, raw materials used in the manufacturing of our product candidates, laboratory supplies for our preclinical studies and planned clinical trials … or delays or disruptions in the market for the raw materials or active pharmaceutical ingredients, including shortages caused by the purchase of such raw
10-Q
g2x9hzkv
3 Sep 20
Quarterly report
4:19pm
424B4
mkrvpzeo6qhpfnp81t
24 Jul 20
Prospectus supplement with pricing info
4:01pm
S-1/A
5c4ujetny4c80vgn
20 Jul 20
IPO registration (amended)
6:09am
S-1
4kf09 wv5w
2 Jul 20
IPO registration
4:02pm
DRS/A
kqwe4
12 Jun 20
Draft registration statement (amended)
12:00am
DRS
v6orud 430eh5n
8 May 20
Draft registration statement
12:00am
- Prev
- 1
- Next